Of note, CBX7 was downregulated in N3 samples compared to N1 and N2 samples, suggesting that patients with a low expression of CBX7 harbored more lymph node metastasis. This evidence concerns the gene CBX7 and metastatic malignant neoplasm in the lymph nodes.